IP Library Granted Patent US 9,554,920
Granted Patent B2
US 9,554,920 · App. 12/267,985 · Granted Jan 31, 2017

Bone matrix compositions having nanoscale textured surfaces

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,554,920
App. No.
12/267,985
Granted
Jan 31, 2017
Kind
B2
Abstract

Bone matrix compositions having nanoscale textured surfaces and methods for their production are provided. In some embodiments, bone matrix is prepared for implantation and retains nanoscale textured surfaces. In other embodiments, nanostructures are imparted to bone matrix wherein collagen fibrils on the surface of the bone matrix have been compromised, thus imparting a nanoscale textured surface to the bone matrix. Generally, these methods may be applied to mineralized or demineralized bone including partially or surface demineralized bone.

Claims (7)

1. A demineralized bone matrix composition comprising lyophilized demineralized bone particles comprising an imparted nanoscale textured surface comprising collagen nanofibers electrospun onto the demineralized bone particles, wherein the imparted surface includes at least 60% non-denatured collagen, wherein the composition has less than about 15% moisture content, wherein the nanoscale textured surface comprises nanostructures each having a length ranging from approximately 40 nm to approximately 600 nm, the nanostructures comprising nanofibers, and the demineralized bone matrix composition further comprising a hydrogel carrier.

2. The demineralized bone matrix of claim 1 , wherein the surface includes at least 75% non-denatured collagen.

3. The demineralized bone matrix of claim 1 , wherein the surface includes at least approximately 90% non-denatured collagen.

4. The demineralized bone matrix of claim 1 , wherein the nanostructures have encapsulated biological active molecules.

5. The demineralized bone matrix of claim 1 , wherein the nanoscale textured surface comprises nanostructures ranging from approximately 50 to approximately 500 nm in at least one dimension.

6. The demineralized bone matrix of claim 1 , further comprising a hydrogel carrier that does not contain calcium phosphate.

7. The demineralized bone matrix of claim 1 , wherein the hydrogel carrier comprises dextran, pluronics, or N,O-carboxymethylchitosan glucosamine (NOCC).

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 28, 2011
From: OSTEOTECH, INC.
To: WARSAW ORTHOPEDIC, INC.
Reel/Frame 026196/0585 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 15, 2009
From: WEI, GUOBAO; BEHNAM, KEYVAN; FORSYTH, NANETTE
To: OSTEOTECH, INC.
Reel/Frame 022690/0342 →